Special Issue on Cancer Biomarkers

SP16_TEAMFacility_KL-4228, Translating Engineering Advances to Medicine (TEAM), UC Davis, CA, USA, May 19, 2016 | © Courtesy of UC Davis College of Engineering/Flickr.
SP16_TEAMFacility_KL-4228, Translating Engineering Advances to Medicine (TEAM), UC Davis, CA, USA, May 19, 2016 | © Courtesy of UC Davis College of Engineering/Flickr.

The journal Open Medicine invites submissions for its topical issue entitled “Cancer Biomarkers.”


GUEST EDITOR

Qian Liu, Tianjin Medical University General Hospital, China.


DESCRIPTION

At present there are a growing number of scientifically investigated biomolecules.  Research efforts are increasingly made to understand the potential role of biomolecules as cancer biomarker for diagnostic, prognostic and therapeutic purposes.

Intriguingly, the state of the art in the field of cancer biomarker research shows both promising empirical results and research projects leading to failures. In oncology, clinical molecular diagnostics and biomarker discoveries  are advancing rapidly. Medical scholars begin to understand the complex mechanisms that transform a normal cell into an abnormal one.

Recent advances in multiplex genotyping technologies and high-throughput genomic profiling by next-generation gene sequencing approaches make possible the rapid and comprehensive analysis of the cancer genome of individual patients even from very little tumor biopsy material.

Thus, this topical issue invites submissions from all aspects of cancer biomarker research. This includes original research, such as clinical trials and translational or basic research results. As well, reviews and opinion pieces are encouraged to be submitted.

This special issue seeks to contribute crucially to the development of cancer biomarker research.


HOW TO SUBMIT

Please contact Guest Editor Dr. Qian Liu liuqian@lungca.org, and Managing Editor Magdalena Wierzchowiecka (Magdalena.Wierzchowiecka@degruyteropen.com) to let know that you are going to submit a paper to Special Issue.

Prospective authors are invited to feel free to register at the paper processing system of Open Medicine, to submit their papers: www.editorialmanager.com/openmed

All papers will go through the review process of Open Medicine. It ensures high standards, as part of its fast, fair and comprehensive peer-review procedures.

Instructions for authors are available here.

In case of any questions please contact Guest Editor (liuqian@lungca.org) or Managing Editor (Magdalena.Wierzchowiecka@degruyteropen.com).

Authors of Open Medicine benefit from:

  • transparent, comprehensive and fast peer review procedures;
  • efficiency en route to fast-track publication and a full advantage of De Gruyter’s e-technology platform;
  • free language assistance for authors from non-English speaking regions.

Edited by Pablo Markin


Featured Image Credits: SP16_TEAMFacility_KL-4228, Translating Engineering Advances to Medicine (TEAM), UC Davis, CA, USA, May 19, 2016 | © Courtesy of UC Davis College of Engineering/Flickr.


You may also like...

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.